Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

(2022) Emma K. Accorsi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

(2022) Delphine Planas et al.   NATURE

Effectiveness of COVID-19 booster vaccines against covid-19 related symptoms, hospitalisation and death in England

(2022) Nick Andrews et al.   NATURE MEDICINE

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

(2022) Mark G. Thompson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study

(2022) Susana Monge et al.   LANCET INFECTIOUS DISEASES

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine

(2022) Edson D. Moreira et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

(2022) Laith J. Abu-Raddad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection

(2021) George N Ioannou et al.   CLINICAL INFECTIOUS DISEASES

Development of COVIDVax Model to Estimate the Risk of SARS-CoV-2–Related Death Among 7.6 Million US Veterans for Use in Vaccination Prioritization

(2021) George N. Ioannou et al.   JAMA Network Open

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

(2021) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System

(2021) George N. Ioannou et al.   ANNALS OF INTERNAL MEDICINE

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

(2021) Noam Barda et al.   LANCET

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans

(2021) Barbra A. Dickerman et al.   NEW ENGLAND JOURNAL OF MEDICINE

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

(2021) Ronen Arbel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Variance estimation when using propensity‐score matching with replacement with survival or time‐to‐event outcomes

(2020) Peter C. Austin et al.   STATISTICS IN MEDICINE

Automated EHR score to predict COVID-19 outcomes at US Department of Veterans Affairs

(2020) Thomas F. Osborne et al.   PLoS One

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

(2020) George N. Ioannou et al.   JAMA Network Open

Sex differences in vaccine-induced humoral immunity

(2018) Stephanie Fischinger et al.   Seminars in Immunopathology

Target trial emulation: teaching epidemiology and beyond

(2017) Jeremy A. Labrecque et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

(2016) Miguel A. Hernán et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

(2016) Miguel A. Hernán et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Negative Controls

(2010) Marc Lipsitch et al.   EPIDEMIOLOGY